YU33692A - Derivati benzimidazola i postupak njihovog dobijanja - Google Patents

Derivati benzimidazola i postupak njihovog dobijanja

Info

Publication number
YU33692A
YU33692A YU33692A YU33692A YU33692A YU 33692 A YU33692 A YU 33692A YU 33692 A YU33692 A YU 33692A YU 33692 A YU33692 A YU 33692A YU 33692 A YU33692 A YU 33692A
Authority
YU
Yugoslavia
Prior art keywords
radical
alkyl
hydroxyl
preparation
aryl
Prior art date
Application number
YU33692A
Other languages
English (en)
Other versions
YU48826B (sh
Inventor
M.R. Cuberes - Altisent
C.J. Frigola
Corominas Juan Pares
Original Assignee
Laboratorios Del Dr. Esteve S.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Laboratorios Del Dr. Esteve S.A. filed Critical Laboratorios Del Dr. Esteve S.A.
Publication of YU33692A publication Critical patent/YU33692A/sh
Publication of YU48826B publication Critical patent/YU48826B/sh

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D249/00Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/081,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Rheumatology (AREA)
  • Immunology (AREA)
  • Pain & Pain Management (AREA)
  • Pulmonology (AREA)
  • Anesthesiology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

Abstract

Ovaj pronalazak se odnosi na nove derivate benzimidazola koji su naznačeni time što su opšte formule I, i na njihove terapijski prihvatljive soli, u kojoj - R1 i R2, koji su isti ili različiti, pretstavljaju vodonik ili halogeni atom, niži alkil radikal, hidroksilni radikal, alkoksi radikal, alkil karboksilatni radikal, ili aril ili supstituisani aril radikal, - n može da ima vrednosti 0 ili 1, - m može da ima vrednosti 2 do 4, - X, Y, Z i W, koji su isti ili različiti, i koji mogu čak da obrazuju deo drugog aromatskog ili nearomatskog prstena, pretstavljaju atom azota ili ugljenični atom vezan za vodonik ili za halogeni atom, ili drugi alkil, aril, karboksialkil, karboksilni, hidroksilni, alkil hidrok-silni, sulfonski ili alkilsulfonski radikal. Pronalazak obuhvata i postupak za dobijanje navedenih derivata benzimidazola.
YU33692A 1991-04-05 1992-03-31 Derivati benzimidazola i postupak njihovog dobijanja YU48826B (sh)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9104171A FR2674856B1 (fr) 1991-04-05 1991-04-05 Nouveaux antihistaminiques non sedatifs, derives de benzimidazole, leur procede de preparation et leur utilisation en tant que medicaments.

Publications (2)

Publication Number Publication Date
YU33692A true YU33692A (sh) 1995-03-27
YU48826B YU48826B (sh) 2002-03-18

Family

ID=9411523

Family Applications (1)

Application Number Title Priority Date Filing Date
YU33692A YU48826B (sh) 1991-04-05 1992-03-31 Derivati benzimidazola i postupak njihovog dobijanja

Country Status (28)

Country Link
US (1) US5214040A (sh)
EP (1) EP0507696B1 (sh)
JP (1) JP3060054B2 (sh)
KR (1) KR970011298B1 (sh)
CN (1) CN1028367C (sh)
AT (1) ATE126228T1 (sh)
AU (1) AU647904B2 (sh)
BG (1) BG60678B1 (sh)
BR (1) BR1100983A (sh)
CA (1) CA2065061A1 (sh)
CZ (1) CZ279506B6 (sh)
DE (1) DE69203911T2 (sh)
DK (1) DK0507696T3 (sh)
ES (1) ES2046110B1 (sh)
FI (1) FI99112C (sh)
FR (1) FR2674856B1 (sh)
GR (1) GR3017643T3 (sh)
HU (1) HU214316B (sh)
IL (1) IL101483A (sh)
IS (1) IS1639B (sh)
MX (1) MX9201556A (sh)
NO (1) NO179552C (sh)
NZ (1) NZ242208A (sh)
PL (1) PL167720B1 (sh)
RO (1) RO109198B1 (sh)
RU (1) RU2099336C1 (sh)
TW (1) TW208003B (sh)
YU (1) YU48826B (sh)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1264456B1 (it) * 1993-05-14 1996-09-23 Dompe Farmaceutici Spa Derivati del 2-(benzimidazol-2-il)-1,3-diaminopropano farmacologicamente attivi.
FR2727865B1 (fr) * 1994-12-08 1997-07-18 Esteve Labor Dr Utilisation des derives de 2-(4-(azolybutyl)-piperazinyl- (methyl))-benzimidazole et analogues ainsi que de leurs sels, pour la preparation de medicaments destines au traitement ou a la prophylaxie de l'asthme
US5773616A (en) * 1995-02-15 1998-06-30 Neurogen Corporation Certain bridged 4-phenyl-2-aminomethylimidazoles; new dopamine receptor subtype specific ligands
WO1996025411A1 (en) * 1995-02-15 1996-08-22 Neurogen Corporation Certain bridged 4-phenyl-2-aminomethylimidazoles; new dopamine receptor subtype specific ligands
FR2731618B1 (fr) * 1995-03-14 1997-08-01 Esteve Labor Dr Composition ophtalmique topique comprenant un derive de 2-(4-(azolylbutyl)-piperazinyl-methyl)-benzimidazole, notamment pour le traitement de la conjonctivite allergique
US6211199B1 (en) 1995-11-17 2001-04-03 Aventis Pharmaceuticals Inc. Substituted 4-(1H-benzimidazol-2-yl-amino)piperidines useful for the treatment of allergic diseases
US6423704B2 (en) 1995-12-20 2002-07-23 Aventis Pharmaceuticals Inc. Substituted 4-(1H-benzimidazol-2-yl)[1,4]diazepanes useful for the treatment of allergic diseases
US6194406B1 (en) 1995-12-20 2001-02-27 Aventis Pharmaceuticals Inc. Substituted 4-(1H-benzimidazol-2-yl)[1,4]diazepanes useful for the treatment of allergic disease
US5932571A (en) * 1996-02-21 1999-08-03 Hoechst Marion Roussel, Inc. Substituted N-methyl-N-(4-(4-(1H-benzimidazol-2-yl) {1,4}diazepan-1-yl)-2-(aryl) butyl) benzamides useful for the treatment of allergic diseases
US5998439A (en) 1996-02-21 1999-12-07 Hoescht Marion Roussel, Inc. Substituted N-methyl-N-(4-(piperidin-1-yl)-2-(aryl)butyl)benzamides useful for the treatment of allergic diseases
US5922737A (en) * 1996-02-21 1999-07-13 Hoechst Marion Roussel, Inc. Substituted N-methyl-N-(4-(4-(1H-Benzimidazol-2-YL-amino) piperidin-1-YL)-2-(arlyl) butyl) benzamides useful for the treatment of allergic diseases
TWI225488B (en) * 1999-12-21 2004-12-21 Janssen Pharmaceutica Nv Derivatives of homopiperidinyl substituted benzimidazole analogues
NZ520402A (en) * 2000-01-19 2006-04-28 Cadila Healthcare Ltd Novel compounds having hypolipedemic, hypocholesteremic activites, process for their preparation and pharmaceutical compositions containing them
HUP0301550A2 (hu) * 2000-10-31 2003-09-29 Basf Aktiengesellschaft Hiper-elágazó poliuretánok alkalmazása nyomdafestékek elżállítására
JP2005532991A (ja) * 2002-01-10 2005-11-04 ニューロジェン・コーポレーション メラニン凝集ホルモン受容体リガンド:置換2−(4−ベンジル−ピペラジン−1−イルメチル)−及び2−(4−ベンジル−ジアゼパン−1−イルメチル)−1h−ベンゾイミダゾールアナログ
CN101089000B (zh) 2006-06-16 2011-01-05 北京大学 螺环哌嗪季铵盐类化合物及其制备方法和应用
RU2533825C2 (ru) * 2009-06-11 2014-11-20 Сиена Байотек С.П.А. ПРОИЗВОДНЫЕ БЕНЗИМИДАЗОЛА И ИМИДАЗО[4,5-с]ПИРИДИНА, В КАЧЕСТВЕ АНТАГОНИСТА ПУТИ HEDGEHOG
LT2938597T (lt) * 2012-12-27 2017-01-25 Alzprotect N-(3-(4-(3-(diizobutilamino)propil)piperazin-1-il)propil)-1h-benzo[d]imidazol-2-amino sulfatinės druskos, jų paruošimas ir panaudojimas
KR102057075B1 (ko) * 2018-11-30 2019-12-19 우승열 페트병에 장착되는 여과장치

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4200641A (en) * 1976-12-21 1980-04-29 Janssen Pharmaceutica, N.V. 1-[(Heterocyclyl)-alkyl]-4-diarylmethoxy piperidine derivatives
DE3336409A1 (de) * 1983-10-06 1985-04-18 Ludwig Heumann & Co GmbH, 8500 Nürnberg Chinazolinderivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
US5010075A (en) * 1987-04-24 1991-04-23 Syntex Pharmaceuticals Ltd. Substituted imidazolyl-alkyl-piperazine and -diazepine derivatives
CA1317939C (en) * 1987-07-01 1993-05-18 Janssen Pharmaceutica Naamloze Vennootschap ¬(bicyclic heterocyclyl)methyl and -hetero| substituted hexahydro-1h-azepines and pyrrolidines
FR2665161B1 (fr) * 1990-07-26 1992-11-27 Esteve Labor Dr Nouveaux derives de benzimidazole, leur preparation et leur application en tant que medicaments.

Also Published As

Publication number Publication date
BG96180A (bg) 1993-12-24
KR970011298B1 (ko) 1997-07-09
HU214316B (hu) 1998-03-02
FR2674856B1 (fr) 1993-07-30
FI921473A0 (fi) 1992-04-03
AU1397992A (en) 1992-10-08
FI99112B (fi) 1997-06-30
DE69203911T2 (de) 1995-12-07
YU48826B (sh) 2002-03-18
NO179552B (no) 1996-07-22
GR3017643T3 (en) 1996-01-31
NO921315D0 (no) 1992-04-03
FI921473A (fi) 1992-10-06
EP0507696A1 (fr) 1992-10-07
IS3832A (is) 1992-10-06
DK0507696T3 (da) 1995-09-18
HUT60732A (en) 1992-10-28
NZ242208A (en) 1993-10-26
CN1065460A (zh) 1992-10-21
BG60678B1 (bg) 1995-12-29
PL294101A1 (en) 1992-11-30
ATE126228T1 (de) 1995-08-15
NO179552C (no) 1996-10-30
JPH0597846A (ja) 1993-04-20
HU9201145D0 (en) 1992-06-29
JP3060054B2 (ja) 2000-07-04
TW208003B (sh) 1993-06-21
FR2674856A1 (fr) 1992-10-09
IL101483A (en) 1995-12-08
CZ279506B6 (cs) 1995-05-17
ES2046110A1 (es) 1994-01-16
KR920019781A (ko) 1992-11-20
MX9201556A (es) 1992-10-01
EP0507696B1 (fr) 1995-08-09
RO109198B1 (ro) 1994-12-30
BR1100983A (pt) 1999-10-13
RU2099336C1 (ru) 1997-12-20
CS101792A3 (en) 1992-10-14
DE69203911D1 (de) 1995-09-14
IS1639B (is) 1997-03-25
ES2046110B1 (es) 1994-08-01
FI99112C (fi) 1997-10-10
PL167720B1 (pl) 1995-10-31
CA2065061A1 (fr) 1992-10-06
NO921315L (no) 1992-10-06
CN1028367C (zh) 1995-05-10
US5214040A (en) 1993-05-25
AU647904B2 (en) 1994-03-31
IL101483A0 (en) 1992-12-30

Similar Documents

Publication Publication Date Title
YU33692A (sh) Derivati benzimidazola i postupak njihovog dobijanja
CY1108313T1 (el) Παραγωγα της κινολινης και η χρηση τους ως προσδεματων 5-ht6
NO912859D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive benzinidazoler.
ES2168304T3 (es) Derivados del taxol.
ES2156853T3 (es) Derivados de quinolina.
DE60139639D1 (de) Substituierte thiazolderivate mit 3-pyridylgruppen, verfahren zu deren herstellung und deren verwendung
FR2665161B1 (fr) Nouveaux derives de benzimidazole, leur preparation et leur application en tant que medicaments.
EA200400641A1 (ru) Производные 4-фенил-1-пиперазинила, -пиперидинила и -тетрагидропиридила и содержащая их фармацевтическая композиция
ES2091489T3 (es) Derivados de imidazol y composiciones farmaceuticas que los contienen.
ES2120686T3 (es) Derivados de bacatin y procedimientos para prepararlos.
NZ225528A (en) Benzimidazoles substituted in the 2 position by n(4-n-guanidyl) piperidinyl radicals; preparations thereof; pharmaceutical compositions
DK149083D0 (da) Fremgangsmade til fremstilling af 2-pyrrolin-3-carbonitrilderivater